StonvexLoading…
StonvexStonvexStonvexCore line items from IART's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.64B | $1.61B | $1.54B | $1.56B |
Operating Income | $-493.37M | $28.41M | $111.53M | $238.92M |
Net Income | $-516.47M | $-6.94M | $67.74M | $180.55M |
EPS (Diluted) | $-6.74 | $-0.09 | $0.84 | $2.16 |
Total Assets | $3.60B | $4.04B | $3.78B | $3.89B |
Total Liabilities | $2.56B | $2.49B | $2.19B | $2.09B |
Cash & Equivalents | $235.05M | $246.38M | $276.40M | $456.66M |
Free Cash Flow OCF − CapEx | $-31.05M | $24.96M | $73.09M | $222.13M |
Shares Outstanding | 76.67M | 77.01M | 80.34M | 83.52M |